65.00
+1.00
+(1.56%)
At close: January 10 at 9:07:20 AM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 9 | 1 | 23 | 24 |
| Avg. Estimate | 14.21B | 13.54B | 53.33B | 57B |
| Low Estimate | 13.8B | 13.54B | 52.6B | 54.16B |
| High Estimate | 14.64B | 13.54B | 53.84B | 59.58B |
| Year Ago Sales | 12.02B | 12.68B | 45.81B | 53.33B |
| Sales Growth (year/est) | 18.20% | 6.75% | 16.41% | 6.88% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ZEGA.F | -- | -- | -- | -- |
| S&P 500 | 8.66% | 11.51% | 14.05% | 13.39% |
Upgrades & Downgrades
| Upgrade | UBS: Sell to Neutral | 11/20/2024 |
| Upgrade | Erste Group: Hold to Buy | 9/11/2024 |
| Maintains | TD Cowen: Buy to Buy | 8/12/2024 |
| Maintains | Argus Research: Buy to Buy | 5/30/2024 |
| Initiated | Goldman Sachs: Buy | 5/30/2024 |
| Maintains | BMO Capital: Outperform to Outperform | 4/26/2024 |
Related Tickers
YPH.SG Astellas Pharma Inc
9.25
-0.84%
NOV.SG Novo Nordisk A/S
83.82
-1.47%
NVSEF Novartis AG
99.24
0.00%
LLY.F Eli Lilly and Company
774.00
+1.08%
SAN.PA Sanofi
95.61
-0.72%
BAYRY Bayer Aktiengesellschaft
5.12
+0.99%
SNY Sanofi
48.73
-1.02%
GSK GSK plc
33.09
-1.96%
ABBV AbbVie Inc.
175.17
-1.87%
PFE Pfizer Inc.
26.72
-0.52%